Clinical Pharmacokinetics of Methotrexate1

This publication has 59 references indexed in Scilit:

• Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity
  New England Journal of Medicine, 1977
• PURITY OF METHOTREXATE
  The Lancet, 1975
• Reappearance of dihydrofolate reductase in rodent tissues following methotrexate administration
  Journal of Pharmacokinetics and Biopharmaceutics, 1975
• Stoichiometric inhibition of mammalian dihydrofolate reductase by the γ-glutamyl metabolite of methotrexate, 4-amino-4-deoxy-N10-methylpteroylglutamyl-γ-glutamate
  Biochemical and Biophysical Research Communications, 1975
• Threshold Methotrexate Concentration for In Vivo Inhibition of DNA Synthesis in Normal and Tumorous Target Tissues
  Journal of Clinical Investigation, 1973
• Polygammaglutamyl metabolites of methotrexate
  Biochemical and Biophysical Research Communications, 1973
• METHOTREXATE IMPURITIES
  The Lancet, 1972
• Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion pattern
  Published by Elsevier ,1972
• Methotrexate Hepatotoxicity in Psoriasis--Comparison of Different Dose Regimens
  BMJ, 1972
• Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)
  New England Journal of Medicine, 1948